Antiviral stockpiling strategies for pandemic influenza: a review of the clinical and cost-effectiveness
Canadian Agency for Drugs and Technologies in Health
Record ID 32011001002
English
Authors' recommendations:
The literature search did not identify any studies that assessed the clinical effectiveness and safety of antiviral stockpiling strategies for pandemic influenza. Evidence from the included economic studies suggested that stockpiling of antivirals for pandemic influenza may be cost-effective, assuming that the next influenza pandemic is severe and has similar characteristics as the simulation models used in the included studies.
Details
Project Status:
Completed
URL for project:
http://www.cadth.ca/media/pdf/htis/jan-2011/L0233_Antiviral_Stockpiling_Pandemic.pdf
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Antiviral Agents
- Cost-Benefit Analysis
- Disease Outbreaks
- Drug Storage
- Influenza, Human
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.